Advertisement

Topics

Circassia receives Innovative Technology contract from Vizient

06:22 EST 8 Feb 2018 | Manufacturing Chemist

Circassia Pharmaceuticals, a specialty pharmaceutical company focused on respiratory disease, has received a multi-year Innovative Technology contract for its NIOX VERO asthma management products from Vizient, the largest member-owned health care company in the US

Original Article: Circassia receives Innovative Technology contract from Vizient

NEXT ARTICLE

More From BioPortfolio on "Circassia receives Innovative Technology contract from Vizient"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...

Asthma
Asthma is caused by inflammation of small tubes, called bronchi, which carry air in and out of the lungs. If you have asthma, the bronchi will be inflamed and more sensitive than normal.  When you come into contact with something that irritates your...